Lloyd Mencinger

Lloyd has over 25 years of medical device experience in Sales & Marketing, General Management, Business Development, Market Development, Strategy, and Operations.

Currently, Lloyd serves as a Principal Advisor at Larta and is the President and CEO of Aqua Medical, Inc., Aqua has developed an endoscopic ablation technology to treat precancerous GI conditions (Barrett’s esophagus & Pancreatic Cysts) to prevent esophageal and pancreatic cancers and potentially treat Type-II Diabetes using duodenal resurfacing.
Each of these are multi-billion dollar potential markets and the treatment is less than 30 minutes outpatient.

Lloyd’s blue chip company experience includes positions at Boston Scientific Corp. as VP Business Development & Strategy for the $1 Billion Endosurgery Group, VP Sales & Marketing Europe, and Director of Operations Europe. At Baxter Healthcare Lloyd was a Field Director and then Head of Business Development for the Cardiovascular Group, (presently Edwards Lifesciences).

Lloyd also has extensive international experience having lived over 12 years as an expatriate in Paris, London, & Maastricht.

Lloyd also has experience in the healthcare provider sector, having held the position of Sr. Vice President of Business Development and Marketing for Tenet Healthcare, a $10 Billion for-profit provider system.

Lloyd’s early stage device company experience includes positions as Vice President International for DFINE Inc., (acquired by Merit Medical for ~$100M), Vice President Sales and Marketing for EndoStim Inc., General Manager Europe for Uptake Medical.

Lloyd holds a MBA cum laude from the University of Southern California and a BS in Chemical Engineering cum laude from California State University at Long Beach.